Device
Lotrafilcon B contact lens (AIR OPTIX® AQUA)
Lotrafilcon B contact lens (AIR OPTIX® AQUA) is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses
NCT00982046
completednot_applicable
Four Week Performance Comparison Between Two Commercially Available Silicone Hydrogel Lenses
NCT01300767
completednot_applicable
One Month Performance Comparison Between Two Commercially Available Silicone Hydrogel Lenses
NCT01300741
Clinical Trials (3)
Showing 3 of 3 trials
NCT00982046Not Applicable
A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses
NCT01300767Not Applicable
Four Week Performance Comparison Between Two Commercially Available Silicone Hydrogel Lenses
NCT01300741Not Applicable
One Month Performance Comparison Between Two Commercially Available Silicone Hydrogel Lenses
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3